Subtype
Endometrial Neoplasm
CI-CAN-00007648Explore in graph →
Non-malignant400 active trials4 approved drugs28 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00007648Explore in graph →
Clinical trials
1,340 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02433080 | Diet and Physical Activity in Uterine Cancer Survivors(DEUS) | completed | N/A | 60 | University College, LondonOTHER | 1 | May 19, 2020 | clinicaltrials |
| NCT01580696 | Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer | completed | Phase 1 / Phase 2 | 51 | COL George Peoples, MD, FACSFED | 1 | May 4, 2020 | clinicaltrials |
| NCT00341458 | Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics | completed | — | 6,086 | National Cancer Institute (NCI)NIH | 1 | Apr 20, 2020 | clinicaltrials |
| NCT00002807 | Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery | completed | N/A | 116 | NCIC Clinical Trials GroupNETWORK | 3 | Apr 6, 2020 | clinicaltrials |
| NCT00004251 | Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer | completed | Phase 2 | 33 | NCIC Clinical Trials GroupNETWORK | 0 | Apr 6, 2020 | clinicaltrials |
| NCT00340262 | Bone Mineral Density and Subsequent Cancer Risk | completed | — | 15,595 | National Cancer Institute (NCI)NIH | 1 | Mar 30, 2020 | clinicaltrials |
| NCT03898947 | Endometrial Changes in Breast Cancer Women With or Without Hormonal Therapies(BETA-1) | completed | — | 1,329 | Università degli Studi dell'InsubriaOTHER | 0 | Mar 25, 2020 | clinicaltrials |
| NCT02834988 | Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer | completed | — | 76 | University of MiamiOTHER | 1 | Mar 12, 2020 | clinicaltrials |
| NCT04302714 | Hysteroscopic vs. Cervical Injection for Sentinel Node Detection of Endometrial Cancer(SLN_EC) | completed | N/A | 165 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Mar 12, 2020 | clinicaltrials |
| NCT03270995 | Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study | completed | N/A | 144 | McGill UniversityOTHER | 1 | Feb 20, 2020 | clinicaltrials |
| NCT03900104 | Cervical and Endometrial Injection for Sentinel Lymph Node Detection in Endometrial Cancer | completed | N/A | 81 | Kocaeli UniversityOTHER | 1 | Feb 20, 2020 | clinicaltrials |
| NCT00478426 | Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer | completed | Phase 2 | 34 | National Cancer Institute (NCI)NIH | 2 | Feb 17, 2020 | clinicaltrials |
| NCT01836484 | Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma(MAPPING) | completed | — | 162 | Barts & The London NHS TrustOTHER | 1 | Feb 13, 2020 | clinicaltrials |
| NCT02387645 | LUDEC Study - Pilot Study of the Lavage of the Uterine Cavity for the Diagnosis of Endometrial Carcinoma(LUDEC) | completed | N/A | 80 | Medical University of ViennaOTHER | 1 | Feb 13, 2020 | clinicaltrials |
| NCT03498924 | Identification and Characterization of Endometrial Cancer With Specific Tumor Markers in Serum and Endometrial Tissue | completed | — | 80 | Fundación Investigación Sanitaria en LeónOTHER | 1 | Feb 11, 2020 | clinicaltrials |
| NCT04240730 | Transvaginal Natural Orifice Endoscopic Surgery for Extremely Obese Patients With Early-stage Endometrial Cancer | completed | — | 6 | Dr. Lutfi Kirdar Kartal Training and Research HospitalOTHER_GOV | 1 | Feb 11, 2020 | clinicaltrials |
| NCT02093546 | Biospecimen Collection in Assessing the Effect of Trametinib With or Without Uprosertib on Biomarkers in Patients With Persistent or Recurrent Endometrial Cancer Enrolled on Trial GOG02290 | completed | — | 40 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 28, 2020 | clinicaltrials |
| NCT01870947 | Assisted Exercise in Obese Endometrial Cancer Patients | completed | N/A | 95 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 27, 2020 | clinicaltrials |
| NCT03540407 | Evaluation of Oncoxin-Viusid® in Cervical Cancer and Endometrial Adenocarcinoma. | completed | Phase 2 | 66 | Catalysis SLINDUSTRY | 1 | Jan 23, 2020 | clinicaltrials |
| NCT01237067 | Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers | completed | Phase 1 | 77 | National Cancer Institute (NCI)NIH | 1 | Dec 17, 2019 | clinicaltrials |
| NCT04175067 | Evaluation of Thiol Disulfide Balance in Stage 1 Endometrium Cancer | completed | — | 117 | Muğla Sıtkı Koçman UniversityOTHER | 1 | Nov 22, 2019 | clinicaltrials |
| NCT00205023 | Disseminated Endometrial Cancer Cells During Sonohysterography | completed | N/A | 25 | University of Wisconsin, MadisonOTHER | 1 | Nov 19, 2019 | clinicaltrials |
| NCT00462969 | Cytologic Analysis of Distention Media as a Screening Test for Endometrial Cancer | completed | N/A | 40 | University of Wisconsin, MadisonOTHER | 1 | Nov 19, 2019 | clinicaltrials |
| NCT00543192 | Sexual Functioning in Endometrial Cancer | completed | — | 73 | University of Wisconsin, MadisonOTHER | 1 | Nov 19, 2019 | clinicaltrials |
| NCT02096783 | Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer | completed | N/A | 15 | University of Wisconsin, MadisonOTHER | 1 | Nov 18, 2019 | clinicaltrials |
| NCT02115477 | Lymphedema After Primary Surgery for Endometrial Cancer(LASEC) | completed | — | 262 | Preben Kjolhede, MD, professorOTHER | 1 | Oct 25, 2019 | clinicaltrials |
| NCT02676726 | STELLA 2 Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer(STELLA-2) | completed | N/A | 208 | Hospital Universitari Vall d'Hebron Research InstituteOTHER | 1 | Oct 24, 2019 | clinicaltrials |
| NCT02068820 | Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG | completed | N/A | 200 | AdventHealthOTHER | 1 | Sep 10, 2019 | clinicaltrials |
| NCT01610375 | Telephone Follow-up After Treatment for Endometrial Cancer(TEACUP) | completed | N/A | 149 | Queensland Centre for Gynaecological CancerOTHER_GOV | 1 | Aug 29, 2019 | clinicaltrials |
| NCT01075386 | The Effects of the Endocrine System on Endometrial Cancer(Ghrelin) | completed | — | 75 | Queensland Centre for Gynaecological CancerOTHER_GOV | 1 | Aug 28, 2019 | clinicaltrials |
| NCT00319748 | Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers | completed | Phase 2 | 15 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Aug 26, 2019 | clinicaltrials |
| NCT01132820 | Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer | completed | Phase 2 | 53 | National Cancer Institute (NCI)NIH | 1 | Aug 8, 2019 | clinicaltrials |
| NCT01266447 | Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer | completed | Phase 2 | 27 | National Cancer Institute (NCI)NIH | 1 | Aug 8, 2019 | clinicaltrials |
| NCT00006089 | Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer | completed | Phase 2 | 34 | National Cancer Institute (NCI)NIH | 1 | Jul 31, 2019 | clinicaltrials |
| NCT00095979 | Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer | completed | Phase 2 | 52 | National Cancer Institute (NCI)NIH | 1 | Jul 24, 2019 | clinicaltrials |
| NCT00096447 | Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer | completed | Phase 2 | 31 | National Cancer Institute (NCI)NIH | 1 | Jul 24, 2019 | clinicaltrials |
| NCT00301964 | Bevacizumab in Treating Patients With Recurrent or Persistent Endometrial Cancer | completed | Phase 2 | 56 | National Cancer Institute (NCI)NIH | 1 | Jul 24, 2019 | clinicaltrials |
| NCT00416455 | Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer | completed | Phase 1 / Phase 2 | 384 | National Cancer Institute (NCI)NIH | 4 | Jul 23, 2019 | clinicaltrials |
| NCT00462826 | VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer | completed | Phase 2 | 49 | National Cancer Institute (NCI)NIH | 1 | Jul 23, 2019 | clinicaltrials |
| NCT00723255 | Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer | completed | Phase 2 | 53 | National Cancer Institute (NCI)NIH | 1 | Jul 23, 2019 | clinicaltrials |
| NCT00729586 | Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer | completed | Phase 2 | 73 | National Cancer Institute (NCI)NIH | 1 | Jul 23, 2019 | clinicaltrials |
| NCT00803062 | Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer | completed | Phase 3 | 452 | National Cancer Institute (NCI)NIH | 2 | Jul 23, 2019 | clinicaltrials |
| NCT01011933 | Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer | completed | Phase 2 | 54 | National Cancer Institute (NCI)NIH | 1 | Jul 23, 2019 | clinicaltrials |
| NCT01281852 | Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer | completed | Phase 1 | 37 | National Cancer Institute (NCI)NIH | 1 | Jul 18, 2019 | clinicaltrials |
| NCT01523678 | Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers | completed | Phase 2 | 108 | Belgian Gynaecological Oncology GroupOTHER | 1 | Jul 10, 2019 | clinicaltrials |
| NCT02646319 | Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations | completed | Early Phase 1 | 2 | Mayo ClinicOTHER | 1 | Jun 6, 2019 | clinicaltrials |
| NCT01289041 | BKM120 as Second-line Therapy for Advanced Endometrial Cancer | completed | Phase 2 | 70 | Novartis PharmaceuticalsINDUSTRY | 13 | May 30, 2019 | clinicaltrials |
| NCT02069158 | Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor(IOSI-NDU-001) | completed | Phase 1 | 17 | Cristiana SessaOTHER | 1 | May 21, 2019 | clinicaltrials |
| NCT02351479 | Hula, a Physical Activity Intervention for Female-Cancer Survivors | completed | N/A | 73 | University of HawaiiOTHER | 1 | Apr 18, 2019 | clinicaltrials |
Data updated 23 days agoSource updated May 19, 2020source: clinicaltrials